Annual Report 2024
Letter to the Shareholders
medmix at a glance
Our Key Figures
Sustainability strategy and impact
Leading brands
Strategy
Business review
Financial review
Healthcare review
Consumer & Industrial review
Sustainability report
Sustainability report
Governance
Strategy and business model
People and culture
Approach and progress
Main performance indicators
Annex
Corporate governance
Corporate Structure and Shareholders
Capital Structure
Board of Directors
Executive Committee
Shareholder Participation Rights
Changes of control and defence measures
Auditors
Information Policy
Compensation report
Overview of the financial year 2024
Compensation governance
Compensation architecture for the Executive Committee
Compensation of the Executive Committee for 2024
Compensation architecture for the Board of Directors
Compensation of the Board of Directors for 2024
Shareholdings
Auditor’s Report
Consolidated financial statements
Income statement
Statement of comprehensive income
Balance sheet
Statement of changes in equity
Statement of cash flows
Notes to the consolidated financial statements
Auditor’s report
Alternative performance measures (APM)
Financial statements of medmix Ltd
Balance sheet of medmix Ltd
Income statement of medmix Ltd
Statement of changes in equity of medmix Ltd
Notes to the financial statements of medmix Ltd
Proposal of the Board of Directors for the appropriation of the available profit
Auditor’s report
Search
search-button